No Accumulation with Repeated Dosing: A first-in-human study of recombinant human T4 (0.0525 g/kg IV) showed dose-proportional increases in Cmax and AUC, consistent terminal clearance across cohorts, and no obvious accumulation after 10 consecutive daily doses (PMID 34346165)
Heavier individuals may require higher doses to achieve equivalent NNMT inhibition due to larger adipose tissue mass and potentially higher baseline NNMT activity
Third, relevant lab values including hemoglobin, ferritin, MCV, and transferrin saturation referenced in the note, not just ordered
The signals involved in repair and resilience can become weaker, slower, or less coordinated
To learn whether BPC-157 is right for your recovery, gut health, or tissue repair goals, schedule a consultation or visit our site to get started
Combine B12 injections with wellness IV therapy for overall nutrient restoration and energy optimization